Origins
- Date back to 1991 when the management team started Genetic Models, Inc (GMI).
- GMI brought to market rodent models such as the Zucker Diabetic Fatty Rat (ZDF), SHHF and ZSF1.
- GMI was acquired by Charles River Laboratories in July 2001.
- PreClinOmics was incorporated in 2001.
Today’s Company
- PreClinOmics has undergone significant growth since its incorporation and is becoming the preclinical contract research company of choice for scientists involved in drug discovery research. PreClinOmics specializes in the design and execution of compound efficacy, PK/PD, ADME and early safety studies in therapeutic areas such as metabolic syndrome, obesity, diabetes, cardiovascular anomalies, renal failure, neurology and cancer.
- Occupying over 23,000 sqft of space, PreClinOmics has the capacity to quickly respond to a sponsor’s request for initiating a study. From the time of initial contact to data finalization the constant and seamless level of communication supports our commitment to everything being sponsor driven.
- PreClinOmics constantly strives to maintain a technological edge so that our sponsors have access to a broad range of services to support their preclinical drug discovery research efforts. Technologies include QNMR, telemetry, LC/MS, and the latest multiplexing capabilities with MesoScale Discovery, Luminex and Rules Based Medicine.
Have Questions?